Cellectar Biosciences (CLRB) Return on Assets (2011 - 2026)
Cellectar Biosciences (CLRB) posted Return on Assets of 0.02% for Q4 2025, up 83.39% sequentially from 0.1% in Q3 2025, and up 4.0% YoY from 0.02% in Q4 2024.
Cellectar Biosciences (CLRB) Return on Assets (2011 - 2026) Analysis & Trends
Cellectar Biosciences has reported Return on Assets for 15 years, with the latest figure at 0.02% in Q4 2025.
- Quarterly Return on Assets rose 4.0% year-over-year to 0.02% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.02% (up 4.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
- Return on Assets advanced to 0.02% in Q4 2025 per CLRB's latest filing, from 0.1% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q1 2021 and troughed at 0.1% in Q2 2025.
- A 5-year average of 0.04% and a median of 0.02% in 2024 frame the typical range for Return on Assets.
- The sharpest annual moves came in 2023 and 2024: Return on Assets dropped 9 bps in 2023, then grew 8 bps in 2024.
- Over 5 years, Return on Assets stood at 0.01% in 2021, then plunged by 681 bps to 0.05% in 2022, then soared by 51 bps to 0.02% in 2023, then sank by 109 bps to 0.05% in 2024, then soared by 68 bps to 0.02% in 2025.
- According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.1%, and 0.1% for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 0.00% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 0.00% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 0.00% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 0.00% |
| 10 | Cellectar Biosciences | 6.63 Mn | 6.63 Mn | - | -0.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.05% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | -0.10% |
| Jun 30, 2025 | -0.10% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.08% |
| Jun 30, 2023 | -0.10% |
| Mar 31, 2023 | -0.06% |
| Dec 31, 2022 | -0.05% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | 0.00% |